Alfonso J. Tobia

932 total citations
35 papers, 757 citations indexed

About

Alfonso J. Tobia is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Alfonso J. Tobia has authored 35 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Alfonso J. Tobia's work include Heart Rate Variability and Autonomic Control (8 papers), Nitric Oxide and Endothelin Effects (6 papers) and Receptor Mechanisms and Signaling (5 papers). Alfonso J. Tobia is often cited by papers focused on Heart Rate Variability and Autonomic Control (8 papers), Nitric Oxide and Endothelin Effects (6 papers) and Receptor Mechanisms and Signaling (5 papers). Alfonso J. Tobia collaborates with scholars based in United States and Canada. Alfonso J. Tobia's co-authors include Robert Falotico, Gerald M. Walsh, Jeffery B. Press, Bernard E. Cabana, Alain H. Rook, James J. McNally, Joan A. Keiser, Richard Rampulla, David Bright and Ronald K. Russell and has published in prestigious journals such as Cancer, Journal of Applied Physiology and Journal of Medicinal Chemistry.

In The Last Decade

Alfonso J. Tobia

33 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso J. Tobia United States 14 285 237 110 77 75 35 757
Neil R. Ackerman United States 15 156 0.5× 170 0.7× 39 0.4× 22 0.3× 21 0.3× 34 912
Dennis Argentieri United States 17 280 1.0× 225 0.9× 44 0.4× 43 0.6× 17 0.2× 25 896
Kiyoshi Yasui Japan 18 210 0.7× 205 0.9× 161 1.5× 102 1.3× 17 0.2× 41 1.1k
Jürgen Sandow Germany 15 91 0.3× 208 0.9× 75 0.7× 17 0.2× 79 1.1× 24 1.0k
Tamás Kriska United States 14 46 0.2× 303 1.3× 208 1.9× 23 0.3× 33 0.4× 37 735
Reza Ahmadi Iran 19 124 0.4× 275 1.2× 45 0.4× 57 0.7× 39 0.5× 61 871
Outi Sareila Finland 17 79 0.3× 306 1.3× 48 0.4× 32 0.4× 52 0.7× 31 945
A. Miroššay Slovakia 15 53 0.2× 215 0.9× 55 0.5× 17 0.2× 43 0.6× 27 486
Jin‐Mo Ku South Korea 19 433 1.5× 415 1.8× 41 0.4× 54 0.7× 25 0.3× 48 967
Wenfeng Liu China 17 110 0.4× 297 1.3× 37 0.3× 20 0.3× 25 0.3× 78 754

Countries citing papers authored by Alfonso J. Tobia

Since Specialization
Citations

This map shows the geographic impact of Alfonso J. Tobia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso J. Tobia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso J. Tobia more than expected).

Fields of papers citing papers by Alfonso J. Tobia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso J. Tobia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso J. Tobia. The network helps show where Alfonso J. Tobia may publish in the future.

Co-authorship network of co-authors of Alfonso J. Tobia

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso J. Tobia. A scholar is included among the top collaborators of Alfonso J. Tobia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso J. Tobia. Alfonso J. Tobia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Couldwell, William T., Alfonso J. Tobia, Bernard E. Cabana, et al.. (2011). A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas. Cancer. 117(21). 4905–4915. 34 indexed citations
2.
Rook, Alain H., Gary S. Wood, Madeleine Duvic, et al.. (2010). A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. Journal of the American Academy of Dermatology. 63(6). 984–990. 66 indexed citations
4.
Combs, Donald W., Stanley C. Bell, Dieter H. Klaubert, et al.. (1990). 6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents. Journal of Medicinal Chemistry. 33(1). 380–386. 86 indexed citations
5.
Dubinsky, Barry, et al.. (1990). Pharmacological profile of RWJ 20085: A new, potent, long‐acting local anesthetic. Drug Development Research. 21(4). 277–289. 17 indexed citations
6.
Kanojia, Ramesh M., Jeffery B. Press, Harvey M. Werblood, et al.. (1989). Renal vasodilators. The role of the 4-substituent in isoquinolin-3-ol cardiovascular agents. 4-Ureido derivatives of isoquinolin-3-ol with selective renal vasodilator properties. Journal of Medicinal Chemistry. 32(5). 990–997. 10 indexed citations
7.
Falotico, Robert, et al.. (1989). Positive Inotropic and Hemodynamic Properties of Flosequinan, a New Vasodilator, and a Sulfone Metabolite. Journal of Cardiovascular Pharmacology. 14(3). 412–418. 26 indexed citations
8.
Falotico, Robert, et al.. (1989). Increased Vasodilator Responsiveness to BRL 34915 in Spontaneously Hypertensive versus Normotensive Rats: Contrast with Nifedipine. Experimental Biology and Medicine. 190(2). 179–185. 6 indexed citations
9.
Russell, Ronald K., Jeffery B. Press, Richard Rampulla, et al.. (1988). Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agents. Journal of Medicinal Chemistry. 31(9). 1786–1793. 147 indexed citations
10.
Falotico, Robert, et al.. (1988). Cardiovascular properties of bemarinone: A new orally active quinazolinone cardiotonic agent. Drug Development Research. 12(3-4). 241–257. 7 indexed citations
11.
Kanojia, Ramesh M., Jeffery B. Press, James J. McNally, et al.. (1988). Cardiotonic agents. Synthesis and inotropic activity of a series of isoquinolin-3-ol derivatives. Journal of Medicinal Chemistry. 31(7). 1363–1368. 28 indexed citations
12.
Katz, Laurence B., et al.. (1987). Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.. Journal of Pharmacology and Experimental Therapeutics. 242(3). 927–933. 4 indexed citations
13.
Lee, Jang Y., et al.. (1981). Reflex cardiovascular responses induced by electrical stimulation of glossopharyngeal nerves in the rat. Journal of Pharmacological Methods. 5(1). 15–27. 1 indexed citations
14.
Tobia, Alfonso J., et al.. (1981). Renal Vasodilator Responses to Captopril in Dogs Pretreated with Indomethacin. Experimental Biology and Medicine. 167(2). 242–247. 4 indexed citations
15.
Walsh, Gerald M., et al.. (1981). Unaltered Maximum Reflex Vasodilatory Capacity of the Perfused Hindquarters of Spontaneously Hypertensive Rats. PubMed. 3(5). 1019–1038. 1 indexed citations
16.
Lee, Jang Y., Gerald M. Walsh, & Alfonso J. Tobia. (1980). Intact hindquarter vascular responses of young spontaneously hypertensive rats to norepinephrine and tyramine. Life Sciences. 26(22). 1877–1883. 4 indexed citations
17.
Chasin, Mark, et al.. (1979). Interaction of prazosin with alpha-adrenergic receptors—In vitro binding and in vivo antagonism. Biochemical Pharmacology. 28(15). 2409–2411. 6 indexed citations
18.
Sternson, Larry A., et al.. (1974). THE METABOLISM OF BETAHISTINE IN THE RAT. Drug Metabolism and Disposition. 2(2). 123–128. 11 indexed citations
19.
Tobia, Alfonso J., Larry A. Sternson, & Gerald M. Walsh. (1974). The Role of Demethylbetahistine in the Depressor Response to Betahistine in the Rat. Experimental Biology and Medicine. 145(3). 778–781. 4 indexed citations
20.
Evans, Richard H. & Alfonso J. Tobia. (1973). Electromagnetic measurement of iliac artery blood flow in the rat: on-line integration of flow. Cardiovascular Research. 7(1). 1–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026